{
  "symbol": "BDMDW",
  "company_name": "Baird Medical Investment Holdings WT",
  "ir_website": "https://ir.bairdmed.com/",
  "structured_data": [
    {
      "section_name": "News Releases",
      "links": [
        {
          "title": "Baird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China",
          "url": "https://ir.bairdmed.com/news-releases/news-release-details/baird-medical-sponsored-and-showcased-microwave-ablation-mwa",
          "content": "[Skip to content](#lfg-main-content)\n\n# Releases Details\n\n## \n\nBaird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China\n\nNovember 25, 2024\n\n[PDF Version](/node/6731/pdf)\n\nNEW YORK, Nov. 25, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a global leader in minimally invasive microwave ablation (MWA) technology, proudly sponsored and participated in the 2024 7th Thyroid Disease Standardized Diagnosis and Treatment Forum and Guangdong Pharmaceutical Society Thyroid Specialist Committee Annual Meeting, held in Guangzhou, China.\n\n[ ![2024 7th Thyroid Disease Forum and Guangdong Thyroid Specialist Committee Annual Meeting](https://mma.prnewswire.com/media/2566303/2024_7th_Thyroid_Disease_Forum_and_Guangdong_Thyroid_Specialist_Committee_Annual_Meeting.jpg) ](https://mma.prnewswire.com/media/2566303/2024_7th_Thyroid_Disease_Forum_and_Guangdong_Thyroid_Specialist_Committee_Annual_Meeting.html)\n\nThis prestigious forum, hosted by the Guangdong Provincial People's Hospital and organized by leading medical and pharmaceutical associations in Guangdong, brought together top experts and healthcare professionals to advance standardized treatment protocols for thyroid diseases. Recognized as a premier platform for academic exchange and technological innovation, the event provided an invaluable opportunity to explore the latest advancements in thyroid care.\n\nAs a sponsor, Baird Medical presented its advanced microwave ablation technology, designed to provide precise, efficient, and minimally invasive options for thyroid treatments. Attendees had the opportunity to learn about Baird's innovations, which enable larger ablation zones and shorter treatment times, setting a new standard for minimally invasive procedures.\n\n\"Baird Medical is thrilled to sponsor and contribute to this highly respected forum, which underscores our dedication to advancing cutting-edge solutions for thyroid disease management,\" said Haimei Wu, Chairwoman of Baird Medical. \"Through our participation, we aim to support medical professionals with the tools and expertise needed to improve patient outcomes globally.\"\n\nThe forum also enabled Baird Medical to engage in meaningful discussions with leading experts, enhance collaborations, and highlight its commitment to expanding the reach of innovative treatments both within China and globally. Sponsoring this influential event further solidifies Baird Medical's position as a leader in the field of minimally invasive treatments for thyroid diseases.\n\n**About Baird Medical** Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit [https://bairdmed.com/](https://c212.net/c/link/?t=0&l=en&o=4311044-1&h=2887134219&u=https%3A%2F%2Fbairdmed.com%2F&a=https%3A%2F%2Fbairdmed.com%2F)\n\n[ ![Baird Medical \\(PRNewsfoto/Baird Medical LLC\\)](https://mma.prnewswire.com/media/2539350/Baird_Logo.jpg) ](https://mma.prnewswire.com/media/2539350/Baird_Logo.html)\n\n![Cision](https://c212.net/c/img/favicon.png?sn=NE65153&sd=2024-11-25) View original content to download multimedia:<https://www.prnewswire.com/news-releases/baird-medical-sponsored-and-showcased-microwave-ablation-mwa-technology-at-the-7th-thyroid-disease-forum-in-china-302315066.html>\n\nSOURCE BDMD\n\nEric Huang, PR Liaison, Baird Medical LLC, Phone: +1 (888) 508-6228, Email: erichuang@bairdmed.com\n"
        },
        {
          "title": "Baird Medical Showcased Microwave Ablation Technology at Massachusetts Society of Otolaryngology Event",
          "url": "https://ir.bairdmed.com/news-releases/news-release-details/baird-medical-showcased-microwave-ablation-technology",
          "content": "[Skip to content](#lfg-main-content)\n\n# Releases Details\n\n## \n\nBaird Medical Showcased Microwave Ablation Technology at Massachusetts Society of Otolaryngology Event\n\nNovember 11, 2024\n\n[PDF Version](/node/6721/pdf)\n\nNEW YORK, Nov. 11, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in microwave ablation technology, proudly participated in the recent Massachusetts Society of Otolaryngology (MSO) event. This year's event centered on emerging trends in Otolaryngology, with a focus on the increasing shift toward office-based surgical procedures.\n\n[ ![Baird Medical \\(PRNewsfoto/Baird Medical LLC\\)](https://mma.prnewswire.com/media/2539350/Baird_Logo.jpg) ](https://mma.prnewswire.com/media/2539350/Baird_Logo.html)\n\nThe MSO is a distinguished organization dedicated to promoting the professional interests of Otolaryngologists in Massachusetts. It provides vital resources on practice economics, fostering professional collaboration, and increasing public awareness of Otolaryngology's critical role in healthcare.\n\nAt the event, Baird Medical showcased its cutting-edge microwave ablation solutions for Head and Neck Surgery, emphasizing their potential to advance minimally invasive, patient-friendly treatment options. With higher precision and reduced procedure time, the technology supports safer, more efficient office-based procedures, improving both patient recovery times and physician workflow.\n\nAttendees engaged with Baird Medical's team to explore how microwave ablation technology aligns with the latest trends in Otolaryngology by delivering precise, minimally invasive treatments in accessible settings. Practitioners expressed strong interest in the technology's ability to enhance patient care outcomes and optimize practice efficiency in an office-based setting.\n\n\"We are delighted by the enthusiastic response to our microwave ablation technology,\" said Haimei Wu, Chairwoman of Baird Medical. \"This engagement underscores our commitment to empowering Otolaryngologists with advanced tools to deliver high-quality care and optimize patient outcomes.\"\n\nBaird Medical remains dedicated to supporting the Otolaryngology community as it adopts innovative approaches that prioritize patient care, accessibility, and efficiency.\n\n**About Baird Medical** Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit [https://bairdmed.com/](https://c212.net/c/link/?t=0&l=en&o=4299036-1&h=3529129829&u=https%3A%2F%2Fbairdmed.com%2F&a=https%3A%2F%2Fbairdmed.com%2F)\n\n![Cision](https://c212.net/c/img/favicon.png?sn=NE52749&sd=2024-11-11) View original content to download multimedia:<https://www.prnewswire.com/news-releases/baird-medical-showcased-microwave-ablation-technology-at-massachusetts-society-of-otolaryngology-event-302300887.html>\n\nSOURCE BDMD\n\nEric Huang, PR Liaison, Baird Medical LLC, Phone: +1 (888) 508-6228, Email: erichuang@bairdmed.com\n"
        },
        {
          "title": "Baird Medical's Advanced Microwave Ablation Solutions Captivate Attendees at the 2024 ATA Meeting",
          "url": "https://ir.bairdmed.com/news-releases/news-release-details/baird-medicals-advanced-microwave-ablation-solutions-captivate",
          "content": "[Skip to content](#lfg-main-content)\n\n# Releases Details\n\n## \n\nBaird Medical's Advanced Microwave Ablation Solutions Captivate Attendees at the 2024 ATA Meeting\n\nNovember 4, 2024\n\n[PDF Version](/node/6716/pdf)\n\nNEW YORK, Nov. 4, 2024 /PRNewswire/ -- Baird Medical (Nasdaq: BDMD), a leader in minimally invasive microwave ablation (MWA) technology, proudly participated in the 2024 American Thyroid Association (ATA) Annual Meeting. This year's event marked a milestone for Baird Medical, as it attracted significant interest from physicians and researchers worldwide, including attendees from the U.S., Europe, and South America.\n\n[ ![ATA Annual Meeting](https://mma.prnewswire.com/media/2547815/Baird_Medical_LLC_ATA_Annual_Meeting.jpg) ](https://mma.prnewswire.com/media/2547815/Baird_Medical_LLC_ATA_Annual_Meeting.html)\n\nThe company's booth was a highlight of the exhibition floor, drawing in a constant stream of visitors eager to learn about Baird's latest innovations. Attendees engaged with the company's representatives, explored demonstrations of MWA technology, and participated in insightful discussions about the clinical benefits and advancements in thyroid treatments.\n\nA major highlight of Baird Medical's Expo Theater session, expertly led by Dr. Helmi Khadra from Houston Methodist Hospital, was an impactful presentation by Dr. Emad Kandil, Professor at Tulane University School of Medicine. Dr. Kandil's presentation featured valuable clinical data, highlighting a compelling patient case where MWA succeeded following an RFA failure. He also offered a comparative analysis of MWA and RFA, along with practical recommendations for clinical application. \"MWA of thyroid nodules is a novel, safe, and effective method for treating appropriately selected benign and malignant thyroid nodules in adults and pediatric populations. It can provide advantages compared to other thermal ablation techniques,\" stated Dr. Kandil. The session concluded with a dynamic Q&A, fostering thought-provoking dialogue and underscoring the medical community's growing interest in MWA.\n\nBuilding on Dr. Kandil's clinical insights, Dr. Feng Han expanded the discussion by focusing on advanced procedural techniques and energy management. An expert from Sun Yat-sen University Cancer Center with extensive experience performing thousands of MWA procedures, Dr. Han shared key strategies for optimizing patient outcomes through refined MWA practices. His presentation provided attendees with a unique perspective on enhancing treatment precision and efficiency, encouraging meaningful discussions with global physicians eager to integrate these techniques into their practice.\n\nThe Expo Theater session concluded with hands-on demonstrations where medical professionals interacted directly with Baird's MWA technology and posed detailed questions about its applications.\n\nBaird Medical's participation at the ATA meeting underscored its dedication to contributing to advancements in thyroid treatment, highlighting its ongoing efforts to support the medical community and foster valuable connections on a global scale. The company remains focused on continuing these efforts and exploring opportunities to advance its role in innovative thyroid care solutions.\n\n**About Baird Medical** Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit [https://bairdmed.com/](https://c212.net/c/link/?t=0&l=en&o=4293862-1&h=1913926145&u=https%3A%2F%2Fbairdmed.com%2F&a=https%3A%2F%2Fbairdmed.com%2F)\n\n[ ![Baird's MWA demonstration](https://mma.prnewswire.com/media/2547816/Baird_Medical_LLC__MWA_demonstration.jpg) ](https://mma.prnewswire.com/media/2547816/Baird_Medical_LLC__MWA_demonstration.html)\n\n[ ![Baird Medical \\(PRNewsfoto/Baird Medical LLC\\)](https://mma.prnewswire.com/media/2539350/Baird_Logo.jpg) ](https://mma.prnewswire.com/media/2539350/Baird_Logo.html)\n\n![Cision](https://c212.net/c/img/favicon.png?sn=NE47314&sd=2024-11-04) View original content to download multimedia:<https://www.prnewswire.com/news-releases/baird-medicals-advanced-microwave-ablation-solutions-captivate-attendees-at-the-2024-ata-meeting-302294994.html>\n\nSOURCE Baird Medical LLC\n\nEric Huang, 315-558-9293, erichuang@bairdmed.com\n"
        }
      ]
    },
    {
      "section_name": "Events",
      "links": [
        {
          "title": "Roth’s 3rd Annual Healthcare Opportunities Conference",
          "url": "https://ir.bairdmed.com/events/event-details/roths-3rd-annual-healthcare-opportunities-conference",
          "content": "[Skip to content](#lfg-main-content)\n\n# Event Details\n\n## Roth’s 3rd Annual Healthcare Opportunities Conference\n\nOct 9, 2024 \n\n### Location\n\nMetropolitan Club, 1 E 60th Street, New York, NY, 10022\n"
        }
      ]
    },
    {
      "section_name": "SEC Filings",
      "links": [
        {
          "title": "Registration statement for certain foreign private issuers",
          "url": "https://ir.bairdmed.com/sec-filings/sec-filing/f-1/0001104659-24-119358",
          "content": "[Skip to content](#lfg-main-content)\n\n# SEC Filing Details\n\n## Document Details\n\nForm\n\n[ F-1 ](/node/6726/html)\n\nFiling Date\n\nNov 15, 2024\n\nDocument Date\n\nNov 15, 2024\n\nForm Description\n\nRegistration statement for certain foreign private issuers\n\nFiling Group\n\nRegistration Statements\n\nCompany\n\nBaird Medical Investment Holdings Ltd.\n\nIssuer\n\nBAIRD MEDICAL INVESTMENT HOLDINGS LTD\n\n## Filing Formats\n\n[View HTML](/node/6726/html)\n\n[Download PDF](/static-files/163c0862-5d3b-4055-968b-6b0ce51aa86d \"0001104659-24-119358.pdf\")\n\n[Download DOC](/static-files/49759de6-5849-4463-b4a0-11f3b3bdedaf \"0001104659-24-119358.rtf\")\n\n[Download XLS](/static-files/390bf224-f767-4c58-9a1b-ed2aa9a751e3 \"0001104659-24-119358.xls\")\n"
        },
        {
          "title": "Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act",
          "url": "https://ir.bairdmed.com/sec-filings/sec-filing/6-k/0001104659-24-113469",
          "content": "[Skip to content](#lfg-main-content)\n\n# SEC Filing Details\n\n## Document Details\n\nForm\n\n[ 6-K ](/node/6711/html)\n\nFiling Date\n\nNov 1, 2024\n\nDocument Date\n\nNov 1, 2024\n\nForm Description\n\nReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act\n\nFiling Group\n\nCurrent Reports\n\nCompany\n\nBaird Medical Investment Holdings Ltd.\n\nIssuer\n\nBAIRD MEDICAL INVESTMENT HOLDINGS LTD\n\n## Filing Formats\n\n[View HTML](/node/6711/html)\n\n[Download PDF](/static-files/a2070faf-6f94-4481-b293-d2a891e43fb0 \"0001104659-24-113469.pdf\")\n\n[Download DOC](/static-files/a770bb8d-04ff-4a62-8012-5651abfc9cb6 \"0001104659-24-113469.rtf\")\n\n[Download XLS](/static-files/1e1195d8-e15d-4362-b96f-c4de80addc5b \"0001104659-24-113469.xls\")\n"
        },
        {
          "title": "Registration of securities of foreign private issuers 12 (b) of the Securities Exchange Act",
          "url": "https://ir.bairdmed.com/sec-filings/sec-filing/20fr12b/0001104659-24-107388",
          "content": "[Skip to content](#lfg-main-content)\n\n# SEC Filing Details\n\n## Document Details\n\nForm\n\n[ 20FR12B ](/node/6686/html)\n\nFiling Date\n\nOct 9, 2024\n\nDocument Date\n\nOct 9, 2024\n\nForm Description\n\nRegistration of securities of foreign private issuers 12 (b) of the Securities Exchange Act\n\nFiling Group\n\nRegistration Statements\n\nCompany\n\nBaird Medical Investment Holdings Ltd.\n\nIssuer\n\nBAIRD MEDICAL INVESTMENT HOLDINGS LTD\n\n## Filing Formats\n\n[View HTML](/node/6686/html)\n\n[Download PDF](/static-files/c56bf9ef-8686-477e-8fc8-88ee489a1f2c \"0001104659-24-107388.pdf\")\n\n[Download DOC](/static-files/a92a9940-9bda-4218-b6b7-21e3cc29db95 \"0001104659-24-107388.rtf\")\n\n[Download XLS](/static-files/d96fb41f-1ed5-4bb9-b139-5b31fe4d0d4e \"0001104659-24-107388.xls\")\n"
        }
      ]
    }
  ]
}